⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 31/03/26 | 07:00:13 | 31 Mar 2026 | Commercial Update | |
| 11/12/25 | 07:20:16 | 11 Dec 2025 | Half-year Report | |
| 17/11/25 | 07:00:13 | 17 Nov 2025 | Aquis Showcase Investor Presentation | |
| 10/11/25 | 11:04:34 | 10 Nov 2025 | AGM 2025 Presentation Materials | |
| 07/11/25 | 14:30:01 | 7 Nov 2025 | Result of AGM | |
| 06/11/25 | 07:00:13 | 6 Nov 2025 | AGM 2025 Update | |
| 16/10/25 | 10:15:00 | 16 Oct 2025 | Proactive Investor Forum Presentation | |
| 14/10/25 | 07:00:14 | 14 Oct 2025 | Notice of AGM | |
| 06/10/25 | 07:00:09 | 6 Oct 2025 | Investor Presentation | |
| 30/09/25 | 08:15:01 | 30 Sept 2025 | Final Results | |
| 11/08/25 | 07:00:11 | 11 Aug 2025 | SKIN + CELL COMMERCIAL WEBSITE NOW OPEN FOR SALES | |
| 06/08/25 | 07:00:13 | 6 Aug 2025 | SKIN + CELL TO LAUNCH | |
| 09/07/25 | 07:00:09 | 9 Jul 2025 | Holding(s) in Company | |
| 30/06/25 | 07:00:14 | 30 Jun 2025 | Subscription, Directors' Dealing and RPT | |
| 18/06/25 | 07:00:09 | 18 Jun 2025 | New Findings on Protective Effects of Skin + CELL | |
| 02/06/25 | 07:00:14 | 2 Jun 2025 | Direct To Customer Agency Agreement Completed | |
| 22/05/25 | 07:00:10 | 22 May 2025 | Commercial Update | |
| 08/04/25 | 07:00:14 | 8 Apr 2025 | Holding(s) in Company | |
| 01/04/25 | 07:00:12 | 1 Apr 2025 | Warrant Extension, Debt Conversion & Equity Issue | |
| 01/04/25 | 07:00:10 | 1 Apr 2025 | Extension of Warrants in Incanthera to 30 Sep 2025 | |
| 28/03/25 | 07:00:10 | 28 Mar 2025 | Commercial Update | |
| 25/03/25 | 15:08:00 | 25 Mar 2025 | Resolution of Allegations of Patent Infringement | |
| 18/12/24 | 07:00:07 | 18 Dec 2024 | Half-year Report | |
| 26/11/24 | 07:00:12 | 26 Nov 2024 | Commercial Update | |
| 29/10/24 | 07:00:06 | 29 Oct 2024 | Further re: Commercial Update | |
| 17/10/24 | 13:05:32 | 17 Oct 2024 | Result of AGM | |
| 26/09/24 | 07:00:15 | 26 Sept 2024 | Commercial Update | |
| 25/09/24 | 07:00:11 | 25 Sept 2024 | Notice of AGM | |
| 09/09/24 | 07:01:00 | 9 Sept 2024 | Extension of Warrants | |
| 27/08/24 | 07:00:13 | 27 Aug 2024 | Final Results | |
| 14/08/24 | 07:00:10 | 14 Aug 2024 | Exercise of Warrants | |
| 11/07/24 | 07:00:12 | 11 Jul 2024 | Commercial Order Update | |
| 05/07/24 | 07:00:08 | 5 Jul 2024 | Aquis Stock Exchange and Investor Hub | |
| 26/06/24 | 08:00:35 | 26 Jun 2024 | Investor Presentation | |
| 25/06/24 | 16:00:00 | 25 Jun 2024 | Holding(s) in Company | |
| 21/06/24 | 14:45:12 | 21 Jun 2024 | Holding(s) in Company | |
| 21/06/24 | 08:00:00 | 21 Jun 2024 | Completion of Subscription | |
| 20/06/24 | 11:38:47 | 20 Jun 2024 | Result of Meeting | |
| 17/06/24 | 07:00:12 | 17 Jun 2024 | Investor Presentation | |
| 10/06/24 | 07:00:09 | 10 Jun 2024 | Appointment of NED & Promotion to the Apex Segment | |
| 06/06/24 | 16:20:00 | 6 Jun 2024 | Holding(s) in Company | |
| 04/06/24 | 07:00:10 | 4 Jun 2024 | AQSE Webinar Presentation | |
| 03/06/24 | 07:00:12 | 3 Jun 2024 | Commercial Update and Subscription | |
| 16/05/24 | 08:07:38 | 16 May 2024 | Investor Presentation | |
| 25/04/24 | 07:00:13 | 25 Apr 2024 | Holding(s) in Company | |
| 23/04/24 | 14:15:01 | 23 Apr 2024 | Further re: Exercise of Warrants | |
| 17/04/24 | 07:00:10 | 17 Apr 2024 | Further re: Exercise of Warrants | |
| 09/04/24 | 15:00:00 | 9 Apr 2024 | Exercise of Warrants | |
| 25/03/24 | 14:30:00 | 25 Mar 2024 | Initiation of Analyst Research and IGTV Interview | |
| 25/03/24 | 07:00:08 | 25 Mar 2024 | Commercial Update |